Plenty to like.
Recruitment done 2 months earlier than promised.
Next top line data in Q3/25 which Dr burns mentions could be statistically robust and to hopefully show some real trends.
Only long term investors will continue to hold from here, the impatient will leave,
DYOR always.
- Forums
- ASX - By Stock
- ATX
- Ann: Completion of Recruitment of ACCENT Trial
ATX
amplia therapeutics limited
Add to My Watchlist
5.26%
!
8.0¢

Ann: Completion of Recruitment of ACCENT Trial, page-44
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.0¢ |
Change
0.004(5.26%) |
Mkt cap ! $31.03M |
Open | High | Low | Value | Volume |
7.5¢ | 8.2¢ | 7.3¢ | $214.1K | 2.726M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 70912 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 21222 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70912 | 0.079 |
1 | 6428 | 0.078 |
1 | 16178 | 0.077 |
1 | 100000 | 0.071 |
3 | 147153 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 20240 | 1 |
0.082 | 222486 | 2 |
0.083 | 300000 | 2 |
0.085 | 80000 | 1 |
0.086 | 20000 | 1 |
Last trade - 15.39pm 18/06/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online